Skip to main content

Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Arena Pharmaceuticals (ARNA) : "I've liked this one. This is not Merck (MRK) , it is speculative though."

DaVita (DVA) : "I'd go with Abbott Laboratories (ABT) . You don't want DaVita."

IAC Interactive (IAC) : "I think this stock is a buy, buy, buy."

Yext (YEXT) : "I think this stock is a buy."

Cramer and the AAP team are focusing on earnings this week. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.

Scroll to Continue

TheStreet Recommends

On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.

Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in ABT.